The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Peptide/protein vaccine delivery system based on PLGA particles
Open accessAbstract
Due to the excellent safety profile of poly (D,L-lactide-co-glycolide) (PLGA) particles in human, and their biodegradability, many studies have focused on the application of PLGA particles as a controlled-release vaccine delivery system. Antigenic proteins/peptides can be encapsulated into or adsorbed to the surface of PLGA particles. The gradual release of loaded antigens from PLGA particles is necessary for the induction of efficient immunity. Various factors can influence protein release rates from PLGA particles, which can be defined intrinsic features of the polymer, particle characteristics as well as protein and environmental related factors. The use of PLGA particles encapsulating antigens of different diseases such as hepatitis B, tuberculosis, chlamydia, malaria, leishmania, toxoplasma and allergy antigens will be described herein. The co-delivery of antigens and immunostimulants (IS) with PLGA particles can prevent the systemic adverse effects of immunopotentiators and activate both dendritic cells (DCs) and natural killer (NKs) cells, consequently enhancing the therapeutic efficacy of antigen-loaded PLGA particles. We will review co-delivery of different TLR ligands with antigens in various models, highlighting the specific strengths and weaknesses of the system. Strategies to enhance the immunotherapeutic effect of DC-based vaccine using PLGA particles can be designed to target DCs by functionalized PLGA particle encapsulating siRNAs of suppressive gene, and disease specific antigens. Finally, specific examples of cellular targeting where decorating the surface of PLGA particles target orally administrated vaccine to M-cells will be highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816 · cited 10×
“Protein is encapsulated in PLGA- rich liquid phase (coacervate) and newly formed microspheres (MSs) are immersed into heptane to quench and solidify micro droplets.(3,22) Nanoprecipitation”
BackgroundMethodInfluentialBiodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Effect of acidic pH on PLGA microsphere degradation and release
Zolnik, B. S., & Burgess, D. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.034 · Cited by 560
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526
Tan, M. L., Choong, P. F. M., & Dass, C. R. (2010) · Peptides · doi:10.1016/j.peptides.2009.10.002 · Cited by 350
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
MAO, S., XU, J., CAI, C., GERMERSHAUS, O., SCHAPER, A., & KISSEL, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.036 · Cited by 283
Cruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., & Figdor, C. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.013 · Cited by 281
Future of the Particle Replication in Nonwetting Templates (PRINT) Technology
Xu, J., Wong, D. H. C., Byrne, J. D., Chen, K., Bowerman, C., & DeSimone, J. M. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209145 · Cited by 208
Passerini, N., & Craig, D. Q. M. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00245-0 · Cited by 165
Research works printed but not linked: 121
- 10.1586/erv.11.126 · DOI
- Amjadi I, 2013, Iran J Pharm Res, 12, 623
- 10.1016/j.nano.2010.02.002 · DOI · Paper page
- Mahboubian A, 2010, Iran J Pharm Res, 9, 369
- 10.1016/j.addr.2004.09.007 · DOI · Paper page
- 10.1016/j.addr.2011.05.021 · DOI · Paper page
- 10.1016/j.addr.2008.12.009 · DOI
- 10.1007/978-1-4939-0345-0_34 · DOI
- 10.1023/A:1026498209874 · DOI · Paper page
- 10.1517/17425247.2.1.29 · DOI · Paper page
- 10.1155/2011/181646 · DOI
- 10.3109/03639049809108571 · DOI · Paper page
- 10.1016/j.biomaterials.2007.08.015 · DOI · Paper page
- 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
- 10.4161/hv.4.1.4886 · DOI
- 10.1351/PAC-REC-10-12-04 · DOI · Paper page
- 10.1016/j.colsurfb.2009.09.001 · DOI · Paper page
- 10.1016/j.addr.2012.10.003 · DOI · Paper page
- 10.1016/j.ejpb.2004.10.006 · DOI · Paper page
- 10.1016/S0168-3659(03)00194-9 · DOI · Paper page
- 10.1002/smll.200801855 · DOI · Paper page
- 10.1016/j.nano.2012.11.001 · DOI
- 10.1016/S0378-5173(02)00342-3 · DOI · Paper page
- 10.1007/s11095-009-0028-7 · DOI
- 10.1038/nature09737 · DOI · Paper page
- 10.1016/j.vetimm.2005.05.004 · doi:10.1016/j.vetimm.2005.05.004
- 10.1016/S0264-410X(01)00192-X · DOI
- 10.1016/j.vaccine.2011.11.057 · DOI
- 10.2174/156720109788680886 · DOI
- 10.1016/j.vaccine.2005.10.032 · DOI
- Huang SS, 2014, Int J Nanomedicine, 9, 813
- 10.4110/in.2011.11.3.163 · DOI
- 10.1016/j.jconrel.2006.01.012 · DOI
- 10.1186/1756-3305-6-34 · DOI
- 10.1016/j.exppara.2013.04.002 · DOI
- 10.1016/j.jconrel.2005.10.010 · DOI
- 10.1002/jps.20472 · doi:10.1002/jps.20472
- 10.1016/S0168-3659(00)00226-1 · DOI
- 10.1002/jps.10538 · DOI
- 10.1016/S0168-3659(98)00050-9 · DOI · Paper page
- 10.1023/A:1016278902839 · DOI
- 10.1016/j.addr.2012.09.004 · DOI · Paper page
- 10.1002/jbm.820240502 · DOI
- 10.1016/j.biomaterials.2012.03.041 · DOI · Paper page
- 10.1016/j.ijpharm.2011.05.049 · DOI · Paper page
- 10.1016/j.ijpharm.2008.04.042 · DOI · Paper page
- 10.1016/S0927-7765(00)00148-X · DOI
- 10.1208/pt0804098 · DOI
- 10.1016/j.ijpharm.2007.11.012 · DOI · Paper page
- 10.1016/S0142-9612(99)00002-2 · DOI · Paper page
- 10.1590/S0100-879X1999000200005 · DOI
- 10.1016/j.ijpharm.2011.01.045 · DOI
- 10.1016/0142-9612(95)93575-X · DOI · Paper page
- 10.1016/j.polymer.2006.01.021 · DOI
- 10.1016/j.ejpb.2012.11.006 · DOI
- 10.1016/S0169-409X(02)00228-4 · DOI · Paper page
- 10.1021/bm050228k · DOI · Paper page
- 10.1081/DDC-100100328 · DOI
- 10.1016/S0168-3659(01)00446-1 · DOI
- 10.1002/jbm.10019 · DOI · Paper page
- 10.1016/j.addr.2014.05.011 · DOI
- 10.1016/j.jconrel.2010.08.012 · DOI · Paper page
- 10.1016/j.ymeth.2006.05.017 · DOI · Paper page
- 10.1016/S0264-410X(00)00433-3 · DOI
- 10.1016/S0264-410X(02)00435-8 · DOI · Paper page
- 10.1016/j.vaccine.2003.10.020 · DOI
- 10.1007/s11095-010-0094-x · DOI
- 10.1016/0264-410X(93)90387-D · DOI · Paper page
- Eldridge JH, 1991, Infect Immun, 59, 2978, 10.1128/IAI.59.9.2978-2986.1991 · DOI · Paper page
- 10.1002/eji.200737984 · DOI · Paper page
- 10.1211/0022357044418 · DOI
- 10.1016/S0264-410X(01)00508-4 · DOI
- 10.1208/s12248-014-9624-5 · DOI
- Xiao X, 2013, Int J Nanomedicine, 8, 4553
- 10.1021/mp100255c · DOI · Paper page
- Tafaghodi M, 2010, Tropical biomedicine, 27, 639
- Santos DM, 2012, Int J Nanomedicine, 7, 2115
- 10.1016/j.nano.2013.04.003 · DOI
- 10.1080/10611860801900462 · DOI
- 10.1208/s12248-009-9089-0 · DOI
- 10.1088/0957-4484/23/32/325101 · DOI
- Fairley SJ, 2013, Int J Nanomedicine, 8, 2085
- 10.1182/blood-2011-07-367615 · DOI · Paper page
- 10.1016/j.ijpharm.2008.08.039 · DOI
- 10.1016/j.addr.2013.05.013 · DOI · Paper page
- 10.3109/02652048.2014.885608 · doi:10.3109/02652048.2014.885608
- 10.1016/j.jconrel.2004.09.014 · DOI · Paper page
- 10.1128/IAI.73.2.828-833.2005 · DOI
- 10.1007/s11095-007-9318-0 · DOI · Paper page
- 10.1007/s00436-010-2176-4 · DOI
- 10.4110/in.2013.13.1.30 · DOI
- 10.1016/j.vaccine.2003.12.032 · DOI · Paper page
- 10.1016/j.biomaterials.2014.05.067 · DOI
- 10.1002/jps.21065 · DOI
- 10.1016/j.ejpb.2008.03.015 · DOI
- 10.1080/10611860903119656 · doi:10.1080/10611860903119656
- 10.1016/j.vaccine.2014.05.071 · DOI
- 10.1016/j.jconrel.2011.07.029 · DOI
- 10.1371/journal.pone.0031472 · doi:10.1371/journal.pone.0031472
- 10.1016/j.vaccine.2006.01.011 · DOI · Paper page
- 10.1080/02652040701443700 · DOI
- 10.1208/s12248-009-9169-1 · DOI
- 10.1016/j.vaccine.2010.06.121 · DOI · Paper page
- 10.1021/mp400092y · doi:10.1021/mp400092y
- 10.1016/j.jconrel.2008.06.003 · DOI
- 10.1002/jbm.a.32860 · DOI
- 10.1016/j.biomaterials.2011.02.011 · DOI
- 10.1016/j.nano.2013.08.012 · DOI
- 10.1080/10611860701637982 · DOI · Paper page
- 10.1016/j.ejpb.2009.04.009 · DOI · Paper page
- 10.3109/10611861003733946 · DOI · Paper page
- 10.1016/j.ijpharm.2014.06.052 · DOI
- 10.1016/j.biomaterials.2013.11.073 · DOI
- Saluja SS, 2014, Int J Nanomedicine, 9, 5231
- 10.1016/S0169-409X(98)00012-X · DOI · Paper page
- 10.1016/j.jconrel.2012.01.043 · DOI · Paper page
- 10.1016/j.jconrel.2014.07.040 · DOI · Paper page
- 10.1016/j.biomaterials.2006.10.034 · DOI
- 10.1016/j.actbio.2013.12.050 · DOI
- 10.1016/j.biomaterials.2013.10.009 · doi:10.1016/j.biomaterials.2013.10.009
- 10.1016/j.jconrel.2014.06.027 · DOI · Paper page
Cited by
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
PLGA-Based Composites for Various Biomedical Applications
Rocha, C. V., Gonçalves, V., da Silva, M. C., Bañobre-López, M., & Gallo, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042034 · Cited by 350
Nanomaterials for cancer immunotherapy
Song, W., Musetti, S. N., & Huang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.017 · Cited by 281
Rational Design of Nanocarriers for Intracellular Protein Delivery
Qin, X., Yu, C., Wei, J., Li, L., Zhang, C., Wu, Q., Liu, J., Yao, S. Q., & Huang, W. (2019) · Advanced Materials · doi:10.1002/adma.201902791 · Cited by 280
Poudel, P., & Park, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040835 · Cited by 124
Metadata
- Authors
- Allahyari, M., & Mohit, E.
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2015-10-29
- Volume
- 12
- Issue
- 3
- Pages
- 806-828
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- OpenAlex
- W2203910881
- Cited by
- 232
- References
- 13
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peptide/protein vaccine delivery system based on PLGA particles. https://app.cochat.ai/papers/10.1080/21645515.2015.1102804
- The paper
- Allahyari, M., & Mohit, E. (2016). Peptide/protein vaccine delivery system based on PLGA particles. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2015.1102804
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.